CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)	Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm	Not yet recruiting	Phase 1 / Phase 2	2025-09-03		NCT07153289

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Berlin Institute of Health	3
Miltenyi Biotec B.V. & Co. KG	2
National Center for Tumor Diseases, Heidelberg	5
Technical University of Munich	85
University Hospital Freiburg	38
University Hospital Tuebingen	123
Wuerzburg University Hospital	52

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.